Evaluation of the potential of a new ribavirin analog impairing the dissemination of ovarian cancer cells

Epithelial ovarian cancers are insidious pathologies that give a poor prognosis due to their late discovery and the increasing emergence of chemoresistance. Development of small pharmacological anticancer molecules remains a major challenge. Ribavirin, usually used in the treatment of hepatitis C vi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wambecke, Anaïs, Laurent-Issartel, Carine, Leroy-Dudal, Johanne, Giffard, Florence, Cosson, Fanny, Lubin-Germain, Nadège, Uziel, Jacques, Kellouche, Sabrina, Carreiras, Franck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905583/
https://www.ncbi.nlm.nih.gov/pubmed/31825993
http://dx.doi.org/10.1371/journal.pone.0225860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905583/
https://www.ncbi.nlm.nih.gov/pubmed/31825993
http://dx.doi.org/10.1371/journal.pone.0225860

Ejemplares similares